Walleye Trading’s Cymabay Therapeutics CBAY Stock Holding History

Walleye Trading’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,800	Closed	-$66.1K	–	5571
2023 Q4	$66.1K	Buy	+2,800	New	+$49.9K	﹤0.01%	4275

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Walleye Trading's CBAY Position: Q1 2023 in Review

Walleye Trading sold out of Cymabay Therapeutics (CBAY) in Q1 2023, closing a stake of 24,412 shares — an estimated $153K sold.

Walleye Trading first reported a position in CBAY in Q3 2015 and held it in 4 quarters. The position peaked at $153K in Q4 2022. 139 funds tracked by Wall St. Rank hold CBAY as of Q1 2023.

Walleye Trading reported no remaining Cymabay Therapeutics position as of Q1 2023 after selling out during the quarter.
Walleye Trading sold 24,412 Cymabay Therapeutics shares in Q1 2023, an estimated $153K.
Walleye Trading first reported a position in Cymabay Therapeutics in Q3 2015 and held it in 4 quarters.
Walleye Trading's Cymabay Therapeutics position peaked at $153K in Q4 2022.
139 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2023.

Based on Walleye Trading's 13F filing for Q1 2023, filed 15 May 2023.